Listen to the podcast to learn more about mRNA Therapeutic Development
In this podcast, Thermo Fisher Scientific’s Senior Product Manager, Linas Pupelis, will discuss the latest development of critical raw materials required to support the synthesis of mRNA for therapeutic development. Today, developing mRNA-based therapies where mRNA is considered a new drug class presents challenges for biopharmaceutical organizations. A major issue in the biopharma industry is lack of high-quality raw material that meet clinical research and manufacturing regulations. In this podcast, you will learn about the design and manufacture of TheraPure reagents, which follow principles of 21 CFR 210/211 and ICH Q7 and how they can help when building solutions to today’s challenges.